Immunotherapy in GI Cancers
Covers checkpoint inhibitors, CAR-T cell therapies, and targeted oncology treatments. Benefits: Delegates gain a comprehensive understanding of immunotherapy breakthroughs and personalized cancer treatment approaches.
Related Conference of Immunotherapy in GI Cancers
January 19-20, 2026
26th International Conference on Gastroenterology and Hepatology
Vienna, Austria
April 20-21, 2026
20th World Congress on Gastroenterology -Therapeutics & Hepatology
Barcelona, Spain
May 21-22, 2026
17th International Conference on Liver Diseases & Hepatology
Aix-en-Provence, France
Immunotherapy in GI Cancers Conference Speakers
Recommended Sessions
- Advances in Liver Transplantation
- Artificial Intelligence in Gastroenterology
- Emerging Therapies for Inflammatory Bowel Disease
- Innovations in Endoscopy
- Advances in Pancreatic Disease Management
- Bariatric Endoscopy & Obesity Management
- Cirrhosis & Portal Hypertension Management
- Early Detection of Gastrointestinal Cancers
- Emerging Biomarkers in Gastroenterology
- FMT & Microbiota-Based Therapies
- Functional GI Disorders & Motility Diseases
- GI Bleeding & Emergency Endoscopy
- Gut Microbiome in GI Diseases
- Immunotherapy in GI Cancers
- NAFLD & NASH Management
- Nutrition & Liver Health
- Pediatric Gastroenterology Breakthroughs
- Post-COVID GI Complications
- Precision Medicine in Hepatology
- Viral Hepatitis Treatment Innovations
Related Journals
Are you interested in
- Advances in Gastrointestinal Oncology - WORLD GASTROENTEROLOGY 2026 (Spain)
- Advances in Gastrointestinal Therapeutics - Gastroenterology – 2025 (France)
- Advances in GERD Treatment - WORLD GASTROENTEROLOGY 2026 (Spain)
- Advances in Liver Transplantation - Gastroenterology-2025 (UAE)
- Advances in Pancreatic Disease Management - Gastroenterology-2025 (UAE)
- Alcoholic Liver Disease: Emerging Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- Artificial Intelligence in Gastroenterology - Gastroenterology-2025 (UAE)
- Bariatric Endoscopy & Obesity Management - Gastroenterology-2025 (UAE)
- Barrett’s Esophagus: Current Therapeutics - WORLD GASTROENTEROLOGY 2026 (Spain)
- Celiac Disease and Gluten-Related Disorders - Gastroenterology – 2025 (France)
- Celiac Disease: Latest Treatment Options - WORLD GASTROENTEROLOGY 2026 (Spain)
- Cirrhosis & Portal Hypertension Management - Gastroenterology-2025 (UAE)
- Colorectal Cancer: Prevention, Screening, and Treatment - Gastroenterology – 2025 (France)
- Diagnostic Biomarkers and Therapeutic Targets in Digestive Diseases - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Digestive System Cancers - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Early Detection of Gastrointestinal Cancers - Gastroenterology-2025 (UAE)
- Emerging Biomarkers in Gastroenterology - Gastroenterology-2025 (UAE)
- Emerging Therapies for Crohn's - WORLD GASTROENTEROLOGY 2026 (Spain)
- Emerging Therapies for Inflammatory Bowel Disease - Gastroenterology-2025 (UAE)
- Endoscopic Innovations and Techniques - Gastroenterology – 2025 (France)
- Endoscopy and Minimally Invasive Gastrointestinal Procedures - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Esophageal Disorders: Current Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- FMT & Microbiota-Based Therapies - Gastroenterology-2025 (UAE)
- Functional GI Disorders & Motility Diseases - Gastroenterology-2025 (UAE)
- Functional GI Disorders: IBS and Beyond - Gastroenterology – 2025 (France)
- Gastrointestinal Disorders and Treatment - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Infections and Antimicrobial Resistance - Gastroenterology – 2025 (France)
- Gastrointestinal Infections and Immunity - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Oncology and Tumor Biology - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Oncology: From Screening to Targeted Therapies - Gastroenterology – 2025 (France)
- Gastrointestinal Stromal Tumors: Novel Therapies - WORLD GASTROENTEROLOGY 2026 (Spain)
- GI Bleeding & Emergency Endoscopy - Gastroenterology-2025 (UAE)
- GI Oncology: Colorectal and Pancreatic Cancers - Gastroenterology – 2025 (France)
- Gut Microbiome in GI Diseases - Gastroenterology-2025 (UAE)
- Gut Microbiota and Gastrointestinal Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gut Microbiota and Metabolic Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Hepatic Encephalopathy: Modern Management Strategies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Hepatitis C Therapeutics - WORLD GASTROENTEROLOGY 2026 (Spain)
- Hepatocellular Carcinoma: Latest Approaches - WORLD GASTROENTEROLOGY 2026 (Spain)
- Hepatology: Liver Disease and Transplantation - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Immunotherapy in GI Cancers - Gastroenterology-2025 (UAE)
- Inflammatory Bowel Disease (IBD): Crohn’s and Ulcerative Colitis - Gastroenterology – 2025 (France)
- Inflammatory Bowel Disease (IBD): Insights and Advancements - Gastroenterology – 2025 (France)
- Inflammatory Bowel Disease and Intestinal Inflammation - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Inflammatory Bowel Diseases - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Innovations in Endoscopy - Gastroenterology-2025 (UAE)
- Innovations in IBD Management - WORLD GASTROENTEROLOGY 2026 (Spain)
- Liver and Pancreatic Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver Cirrhosis and Complications - Gastroenterology – 2025 (France)
- Liver Cirrhosis: New Therapies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Liver Diseases and Hepatic Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver Diseases and Hepatology - Gastroenterology – 2025 (France)
- Microbiome and Gastrointestinal Health - WORLD GASTROENTEROLOGY 2026 (Spain)
- Microbiome and Gut Health - Gastroenterology – 2025 (France)
- NAFLD & NASH Management - Gastroenterology-2025 (UAE)
- NAFLD and NASH Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- New Approaches to Peptic Ulcer Disease - WORLD GASTROENTEROLOGY 2026 (Spain)
- Non-Alcoholic Fatty Liver Disease - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Non-Alcoholic Fatty Liver Disease (NAFLD) and NASH - Gastroenterology – 2025 (France)
- Nutrition & Liver Health - Gastroenterology-2025 (UAE)
- Nutrition and Aging: Geriatric Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Pancreatitis: Modern Therapeutic Strategies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Pediatric and Adolescent Nutrition - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Pediatric Gastroenterology and Nutrition - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Pediatric Gastroenterology Breakthroughs - Gastroenterology-2025 (UAE)
- Pediatric Gastroenterology: Challenges and Innovations - Gastroenterology – 2025 (France)
- Peptic Ulcer and Acid-related Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Peptic Ulcer Disease and H. pylori Infection - Gastroenterology – 2025 (France)
- Plant-Based Nutrition and Sustainable Diets - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Post-COVID GI Complications - Gastroenterology-2025 (UAE)
- Precision Medicine in Hepatology - Gastroenterology-2025 (UAE)
- Role of Microbiota in Digestive Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Therapeutics for Biliary Diseases - WORLD GASTROENTEROLOGY 2026 (Spain)
- Ulcerative Colitis: Innovative Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- Viral Hepatitis Treatment Innovations - Gastroenterology-2025 (UAE)
- Viral Hepatitis: New Treatment Paradigms - WORLD GASTROENTEROLOGY 2026 (Spain)